Australia markets closed

Globus Medical, Inc. (GMED)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
65.49-0.33 (-0.50%)
At close: 04:00PM EDT
65.49 0.00 (0.00%)
After hours: 06:03PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
66,627
122,873
190,169
149,191
102,285
-
Depreciation & amortisation
181,886
144,733
68,252
69,867
62,874
-
Deferred income taxes
-98,901
-57,789
-22,223
-17,615
-4,338
-
Stock-based compensation
61,049
52,742
32,810
30,586
27,073
-
Change in working capital
-138,208
-116,598
-105,262
-17,252
-37,590
-
Accounts receivable
-76,446
-49,914
-50,843
-25,895
10,696
-
Inventory
-56,844
-70,328
-61,745
-11,971
-50,111
-
Accounts payable
-23,892
-14,223
14,418
3,684
-6,352
-
Other working capital
151,722
165,225
104,421
219,376
135,135
-
Other non-cash items
152,140
94,261
2,635
50,909
26,392
-
Net cash provided by operating activities
242,573
243,499
178,468
276,274
198,793
-
Cash flows from investing activities
Investments in property, plant and equipment
-90,851
-78,274
-74,047
-56,898
-63,658
-
Acquisitions, net
-306,015
-296,028
-31,435
-34,488
-33,483
-
Purchases of investments
-39,519
-100,643
-419,534
-622,359
-223,540
-
Sales/maturities of investments
681,777
777,913
414,654
337,806
203,359
-
Net cash used for investing activities
245,392
302,968
-110,362
-375,939
-117,322
-
Cash flows from financing activities
Common stock issued
-
-
-
63,496
72,322
31,036
Common stock repurchased
-308,878
-225,562
-144,493
0
-104,669
-
Other financing activities
-52,555
-18,656
-7,185
-9,349
-6,316
-
Net cash used provided by (used for) financing activities
-350,482
-231,821
-109,962
54,147
-38,663
-
Net change in cash
136,377
316,826
-42,603
-46,328
43,673
-
Cash at beginning of period
217,685
150,466
193,069
239,397
195,724
-
Cash at end of period
355,168
467,292
150,466
193,069
239,397
-
Free cash flow
Operating cash flow
242,573
243,499
178,468
276,274
198,793
-
Capital expenditure
-90,851
-78,274
-74,047
-56,898
-63,658
-
Free cash flow
151,722
165,225
104,421
219,376
135,135
-